HIF1α Modulates Cell Fate Reprogramming Through Early Glycolytic Shift and Upregulation of PDK1–3 and PKM2
Autor: | Raul Bukowiecki, James Adjaye, Sheila Hoffmann, Thorsten Cramer, Barbara Mlody, Erich E. Wanker, Markus Ralser, Alessandro Prigione, Katharina Drews, Nadine Rohwer, Katharina Blümlein |
---|---|
Rok vydání: | 2014 |
Předmět: |
Thyroid Hormones
Pyruvate dehydrogenase kinase Induced Pluripotent Stem Cells Protein Serine-Threonine Kinases PKM2 Biology Cell fate determination Article 03 medical and health sciences 0302 clinical medicine Downregulation and upregulation Neoplasms Humans Cell Lineage Induced pluripotent stem cell 030304 developmental biology 0303 health sciences Gene Expression Regulation Developmental Membrane Proteins Pyruvate Dehydrogenase Acetyl-Transferring Kinase Cell Differentiation Cell Biology Fibroblasts Cellular Reprogramming Hypoxia-Inducible Factor 1 alpha Subunit Embryonic stem cell Mitochondria Cell biology 030220 oncology & carcinogenesis Molecular Medicine Carrier Proteins Glycolysis Reprogramming Pyruvate kinase Developmental Biology |
Zdroj: | Stem Cells. 32:364-376 |
ISSN: | 1549-4918 1066-5099 |
Popis: | Reprogramming somatic cells to a pluripotent state drastically reconfigures the cellular anabolic requirements, thus potentially inducing cancer-like metabolic transformation. Accordingly, we and others previously showed that somatic mitochondria and bioenergetics are extensively remodeled upon derivation of induced pluripotent stem cells (iPSCs), as the cells transit from oxidative to glycolytic metabolism. In the attempt to identify possible regulatory mechanisms underlying this metabolic restructuring, we investigated the contributing role of hypoxia-inducible factor one alpha (HIF1α), a master regulator of energy metabolism, in the induction and maintenance of pluripotency. We discovered that the ablation of HIF1α function in dermal fibroblasts dramatically hampers reprogramming efficiency, while small molecule-based activation of HIF1α significantly improves cell fate conversion. Transcriptional and bioenergetic analysis during reprogramming initiation indicated that the transduction of the four factors is sufficient to upregulate the HIF1α target pyruvate dehydrogenase kinase (PDK) one and set in motion the glycolytic shift. However, additional HIF1α activation appears critical in the early upregulation of other HIF1α-associated metabolic regulators, including PDK3 and pyruvate kinase (PK) isoform M2 (PKM2), resulting in increased glycolysis and enhanced reprogramming. Accordingly, elevated levels of PDK1, PDK3, and PKM2 and reduced PK activity could be observed in iPSCs and human embryonic stem cells in the undifferentiated state. Overall, the findings suggest that the early induction of HIF1α targets may be instrumental in iPSC derivation via the activation of a glycolytic program. These findings implicate the HIF1α pathway as an enabling regulator of cellular reprogramming. Stem Cells 2014;32:364–376 |
Databáze: | OpenAIRE |
Externí odkaz: |